Evidence map›Paper›PMID 24187955›Full record

ArticleChemical research in toxicology2013

PHOS-select iron affinity beads enrich peptides for the detection of organophosphorus adducts on albumin.

Wei Jiang, Yaroslav A Dubrovskii, Ekaterina P Podolskaya, Ekaterina A Murashko, Vladimir Babakov, Florian Nachon, Patrick Masson, Lawrence M Schopfer, Oksana Lockridge

Open access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Wei JiangEppley Institute, University of Nebraska Medical Center , Omaha, Nebraska 68198-5950, United States.
Yaroslav A Dubrovskii
Ekaterina P Podolskaya
Ekaterina A Murashko
Vladimir Babakov
Florian Nachon
Patrick Masson
Lawrence M Schopfer
Oksana Lockridge
University of Nebraska Medical Center · USFederal Medical-Biological Agency · RUInstitute for Analytical Instrumentation · RUSt. Petersburg Research Institute of Radiation Hygiene · RU

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Apar Kishor Ganti · 1985 to 2026
$55.0M
NCI NIH HHS P30 CA036727NCI NIH HHS P30CA036727
6 · The paper itself

Abstract

Albumin is covalently modified by organophosphorus toxicants (OP) on tyrosine 411, but less than 1% of albumin is modified in humans by lethal OP doses that inhibit 95% of plasma butyrylcholinesterase. A method that enriches OP-modified albumin peptides could aid analysis of low dose exposures. Soman or chlorpyrifos oxon treated human plasma was digested with pepsin. Albumin peptides were enriched by binding to Fe(3+) beads at pH 11 and eluted with pH 2.6 buffer. Similarly, mouse and guinea pig albumin modified by chlorpyrifos oxon were digested with pepsin and enriched by binding to Fe(3+) beads. Peptides were identified by MALDI-TOF/TOF mass spectrometry. PHOS-select iron affinity beads specifically enriched albumin peptides VRY411TKKVPQVST and LVRY411TKKVPQVST in a pepsin digest of human plasma. The unmodified as well as OP-modified peptides bound to the beads. The binding capacity of 500 μL of beads was the pepsin digest of 2.1 μL of human plasma. The limit of detection was 0.2% of OP-modified albumin peptide in 0.43 μL of plasma. Enrichment of OP-modified albumin peptides by binding to Fe(3+) beads is a method with potential application to diagnosis of OP pesticide and nerve agent exposure in humans, mice, and guinea pigs.

Indexed as

AnimalsChromatography, AffinityGelsGuinea PigsHumansIron Chelating AgentsMiceOrganophosphorus CompoundsPeptidesSerum AlbuminGelsIron Chelating AgentsOrganophosphorus CompoundsPeptidesSerum Albumin

Identifiers

PMID24187955
PMCPMC3886839
OpenAlexW1984431385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.